|
1717
|
Tivozanib
|
VEGFR1, 2, and 3 tyrosine kinase inhibitor |
€80.00 |
|
3497
|
Tizanidine hydrochloride
|
Centrally acting α2 adrenoceptor agonist |
€90.00 |
|
3076
|
TJ191
|
Potent and selective anti-cancer agent targeting low TβRIII-expressing malignant T-cell leukemia/lymphoma cells |
€120.00 |
|
1004
|
TL 102 hydrobromide
|
Dopamine agonist |
€95.00 |
|
1005
|
TL 232 hydrobromide
|
Dopamine agonist |
€95.00 |
|
1060
|
TL 99 hydrobromide
|
Dopamine agonist |
€95.00 |
|
3099
|
TL02-59
|
Potent, selective and orally active Fgr and Lyn inhibitor |
€120.00 |
|
2344
|
TM 5275
|
Selective and orally active inhibitor of PAI-1 |
€105.00 |
|
2734
|
TM 5441
|
Orally active inhibitor of PAI-1 |
€95.00 |
|
3486
|
TM-N1324
|
Highly potent and selective GPR39 agonist |
€110.00 |
|
3966
|
TM30089 sodium
|
Selective CRTH2 antagonist |
Inquire |
|
4213
|
TMDJ-011
|
Inactive analogue of TMDJ-035 |
€120.00 |
|
4111
|
TMDJ-035
|
First highly potent and selective RyR2 inhibitor |
€130.00 |
|
1507
|
TMI 005
|
TACE/MMP inhibitor |
€150.00 |
|
2180
|
TMP 195
|
HDAC inhibitor (class IIA selective) |
€110.00 |
|
2628
|
TMS
|
CYP1B1 inhibitor that induces apoptosis in human cancer cells |
€75.00 |
|
4270
|
TNG-260
|
First-in-class, orally active, potent, and CoREST-selective deacetylase inhibitor |
Inquire |
|
3865
|
TNO155
|
Selective and orally bioavailable allosteric inhibitor of SHP2 |
Inquire |
|
3624
|
Toceranib phosphate
|
Multi-targeted receptor tyrosine kinase inhibitor |
€60.00 |
|
2072
|
Tofacitinib citrate
|
Potent Janus Kinase 3 (JAK3) inhibitor |
€115.00 |
|
3993
|
Tolcapone
|
Potent, selective, orally active and reversible COMT inhibitor |
€70.00 |
|
2977
|
Toloxatone
|
Reversible MAO-A inhibitor; Antidepressant |
€80.00 |
|
2049
|
Tolterodine L-tartrate
|
Muscarinic receptor (mAChR) antagonist |
€60.00 |
|
1591
|
Tolvaptan
|
Vasopressin (V2) antagonist |
€110.00 |
|
3178
|
Topiroxostat
|
Potent xanthine oxidoreductase (XOR) inhibitor |
€50.00 |
|
2047
|
Torcetrapib
|
Inhibitor of cholesterylester transfer protein (CETP) |
€85.00 |
|
1833
|
Torin 1
|
mTOR inhibitor |
€90.00 |
|
1834
|
Torin 2
|
mTOR inhibitor |
€90.00 |
|
1422
|
TP003
|
GABAA-α3 agonist |
€80.00 |
|
2723
|
TPI-1
|
Selective SHP1 inhibitor |
€95.00 |